100 kVp超低剂量胸部CT机会性骨质疏松筛查的机器学习QCT模型
本研究通过欧洲脊柱体模及508例患者开发并内部验证了100 kVp无体模QCT模型,并在独立CT系统和197例患者中完成外部验证。结果显示100 kVp模型骨密度误差显著低于常规120 kVp模型,与DXA一致性为88.8%,支持超低剂量胸部CT机会性骨质疏松筛查。
要点
- 100 kVp超低剂量胸部CT可用于机会性骨质疏松筛查,平均有效剂量0.82±0.19 mSv。
- 机器学习辅助无体模QCT模型在100 kVp下骨密度测量准确性优于常规120 kVp模型。
- 阅片报告遇到100 kVp胸部CT时,可用该模型进行椎体骨密度机会性筛查。
核心结论
- 100 kVp机器学习辅助无体模QCT模型可从超低剂量胸部CT实现准确骨密度定量,优于常规120 kVp模型。
- 该模型支持跨CT扫描仪的机会性骨质疏松筛查,与DXA一致性为88.8%。
研究设计与样本
- 研究类型为体模研究结合回顾性患者队列,包含模型训练、内部验证与独立外部验证。
- 体模采用欧洲脊柱体模重复扫描16次,患者训练及内部验证共508例。
- 外部验证在独立CT系统进行,包含体模扫描及197例100 kVp胸部CT患者。
- 诊断性能在178例同时具有DXA和胸部CT的个体中评估。
- 所有患者扫描均采用100 kVp超低剂量胸部CT方案。
关键影像表现/征象
- 内部验证中100 kVp模型骨密度误差为2.39±7.12 mg/cm³,显著低于120 kVp模型的16.68±8.26 mg/cm³。
- 外部验证中100 kVp模型骨密度误差为-0.11±4.39 mg/cm³,低于120 kVp模型的13.78±5.10 mg/cm³。
- 100 kVp模型在L1-L3椎体层面均显示优于120 kVp模型的骨密度测量准确性。
诊断标准与关键数值
- 内部验证100 kVp与120 kVp模型骨密度误差比较:2.39±7.12 vs 16.68±8.26 mg/cm³,p<0.0001。
- 外部验证骨密度误差:100 kVp模型-0.11±4.39 mg/cm³,120 kVp模型13.78±5.10 mg/cm³。
- 该模型与DXA诊断一致性为88.8%。
- 平均有效剂量为0.82±0.19 mSv。
临床应用与阅片要点
- 日常阅片遇到100 kVp超低剂量胸部CT时,可应用该模型对椎体骨密度进行机会性筛查。
- 常规120 kVp校准的QCT模型不适用于100 kVp低管电压扫描,需采用专用100 kVp模型。
局限性
- 本研究基于欧洲脊柱体模进行校准,患者数据为回顾性纳入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Opportunistic osteoporosis screening using chest CT is increasingly explored, yet conventional QCT models are calibrated at 120 kVp and may be inaccurate for ultra-low-dose scans acquired at lower tube voltages. This study aimed to develop and validate a machine learning-assisted phantom-less QCT (PL-QCT) model for BMD quantification at 100 kVp and assess its diagnostic performance.
METHODS: Sixteen repeated European Spine Phantom (ESP) scans were acquired using a 100 kVp ultra-low-dose chest CT protocol. A total of 508 patients were retrospectively included for model training and internal validation. A 100 kVp PL-QCT model was developed, calibrated against ESP reference values, and compared with a conventional 120 kVp QCT model. External validation was performed on an independent CT system using ESP scans and 197 patients under a 100 kVp chest CT protocol. Diagnostic performance was evaluated in 178 individuals with both DXA and chest CT.
RESULTS: The mean effective dose was 0.82±0.19 mSv. In internal validation, the 100 kVp model showed significantly lower BMD error than the 120 kVp model (2.39±7.12 vs 16.68±8.26 mg/cm³, p<0.0001), with improved accuracy across L1-L3. External validation confirmed lower error for the 100 kVp model (-0.11±4.39 vs 13.78±5.10 mg/cm³). Agreement with DXA was 88.8%.
CONCLUSION: The 100 kVp machine learning-assisted PL-QCT model enables accurate BMD quantification from ultra-low-dose chest CT, outperforming conventional 120 kVp models and supporting reliable cross-scanner opportunistic osteoporosis screening.
引用
- Wei, Huang, Wu, et al. A Novel Machine Learning-Based Semi-Automated Phantom-Less QCT Model for Osteoporosis Screening on 100 kVp Ultra-Low-Dose Chest CT: A Phantom Study. Acad Radiol. 2026. PMID: 42580992. doi:10.1016/j.acra.2026.07.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。